People
Synlogic, Inc. (Nasdaq: SYBX), a biology-focused clinical-stage company focused on living medicines, has just today announced that effective immediately, Aoife Brennan, M.B., B.Ch., has been appointed as president and chief executive officer (CEO).
Harnessing the body’s own immune system to fight cancer has been one of the key focuses of drugmakers over the past several years. This year, the Nobel committee recognized two research pioneers for their trailblazing efforts in this field.
Pfizer announced its succession plan for when Ian Read steps down as chief executive officer on January 1, 2019. The new chief executive officer will be Albert Bourla, who is currently the company’s chief operating officer.
GENFIT today provides further details on the management changes announced in its September 24, 2018 press release.
Here’s a look at who shook things up in the world of pharma and biotech this week.
Kristi Ebong brings solid understanding of value proposition for voice assistive and conversational AI technologies in healthcare
Dance Biopharm Holdings Inc. is pleased to announce that Anne Whitaker has been appointed as a Director and Chief Executive Officer.
Viracta Therapeutics, Inc. announced the formation of its inaugural Scientific Advisory Board.
GENFIT today announces some key leadership changes to accompany GENFIT into the next stage of its development and its evolution from an R&D biotechnology company to a fully-integrated biopharmaceutical company.
Kavya Kopparaputo be Named a 2018 Davidson Fellow
PRESS RELEASES